Stabilization of soluble high‐affinity T‐cell receptor with de novo disulfide bonds-Reference-Cited by-同舟云学术

Stabilization of soluble high‐affinity T‐cell receptor with de novo disulfide bonds

Published:2019-10-08 Issue:3 Volume:594 Page:477-490
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Sádio Flávio¹,Stadlmayr Gerhard¹,Stadlbauer Katharina¹,Gräf Maximilian¹,Scharrer Agnes¹,Rüker Florian¹,Wozniak‐Knopp Gordana¹^ORCID

Affiliation:

1. Christian Doppler Laboratory for Innovative Immunotherapeutics Department of Biotechnology University of Natural Resources and Life Sciences (BOKU) Vienna Austria

Funder

Austrian Science Fund

Christian Doppler Forschungsgesellschaft

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.13616

Reference53 articles.

1. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

2. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

3. Current progress in innovative engineered antibodies

4. Stable, soluble T-cell receptor molecules for crystallization and therapeutics

5. Display of functional αβ single-chain T-cell receptor molecules on the surface of bacteriophage

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09

2. Expression, Purification, and Crystallization of the Vγ9Vδ2 T-cell Receptor Recognizing Protein/Peptide Antigens;The Protein Journal;2023-08-25

3. The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy;Cells;2022-12-21

4. Application of phage display for T-cell receptor discovery;Biotechnology Advances;2022-01

5. Adoptive T-cell Immunotherapy: Perfecting Self-Defenses;Experientia Supplementum;2022